Abstract:Objective: With the proposal of penumbra theory and development of intra-arterial thrombolysis (such as urokinase), the outcome of ischemic cerebrovascular disease is greatly improved. However, the incidence of hemorrhagic transformation (HT) increased concomitantly, and some studies showed a close relationship between blood pressure and HT. The mechanisms of blood pressure and urokinase effect on the incidence of HT are not clear. In this study, we investigated the effects of the different levels of blood pressure and urokinase on the ischemic lesions, the incidence of HT and the expression of matrix metalloproteinase 9 (MMP-9) in the rat ischemia-reperfusion models. Methods: Temporary focal ischemia was induced in male Sprague-Dawley rats using the intraluminal vascular occlusion method. The animals were assigned into four groups (n=11 in each group): low blood pressure group (LP), normal blood pressure group (NP), high blood pressure group (HP) and urokinase/high blood pressure group (UKHP). Adnephrin was applied to enhance the mean arterial blood pressure (MABP) at the beginning of reperfusion. MABP was maintained 20 mmHg higher than the baseline for 1 hour. Sodium nitroprusside was used to decrease MABP by 20 mmHg lower than the baseline for 1 hour. Both urokinase and adnephrin were used concomitantly in the UKHP group. Neurological deficit scores were evaluated at 2 hours (R2h) and 24 hours (R24h) after reperfusion. All rats were decapitated, their brains were sliced into 15-mu m-thick slices, and the infarct volume and the visible HT were analysed. Three rats in each group were taken for immunohistochemistry and pathological analysis. Results: There was no significant difference in MABP among the groups at the baseline time points (p>0.05), but blood pressure are definitely increased and decreased in the HP, UKHP, and LP groups. Neurological deficit scores showed no significant difference at R2h among the groups (p=0.443). However, neurological deficit scores showed significant differences at R24h among the groups, the neurological deficits scores of rats in the LP group are significantly higher than that in the other groups. Compared with that of 2 hours after reperfusion, neurological deficit scores deteriorated in the LP group (p=0.047) but was improved in the NP, HP and UKHP groups (p=0.076, 0.002, 0.017, respectively) at 24 hours after reperfusion. The infarct volume in the HP group was apparently smaller than that in the LP group (p=0.006). There was indeed a tendency that HT occurred more frequently in the UKHP group (42.8%) than in the HP (25%) and LP (28.5%) groups. MMP-9 expression showed significant increase around the ischemic lesion areas of the UKHP group and significant decrease in the cortical areas of the LP and HP groups but no significant difference in the basal ganglia of rats of all groups. Conclusion: Mild elevation of blood pressure during reperfusion is supposed to improve neurological outcomes in rats following ischemia/reperfusion. The incidence of HT tended to increase with the elevation of blood pressure and the administration of urokinase. Immunohistochemitry analysis indicated that incidence of HT may correlate with excessive expression of MMP-9. [Neurol Res 2009; 31: 204-208]

Urokinase-Type Plasminogen Activator Induces BV-2 Microglial Cell Migration Through Activation of Matrix Metalloproteinase-9

Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells.

PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells.

Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion

[Roles of Protease-Activated Receptor-1 in Thrombin-Induced Brain Injury and Neurogenesis in Rats].

The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation

The uPA/uPAR system in astrocytic wound healing

A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain

Disruption of Tissue Plasminogen Activator Gene Reduces Macrophage Migration

The effects of blood pressure and urokinase on brain injuries after experimental cerebral infarction in rats.

Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.

Neuroprotective Effects Of Valproic Acid On Blood-Brain Barrier Disruption And Apoptosis-Related Early Brain Injury In Rats Subjected To Subarachnoid Hemorrhage Are Modulated By Heat Shock Protein 70/Matrix Metalloproteinases And Heat Shock Protein 70/Akt Pathways

SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells

Urokinase-Type Plasminogen Activator-Induced Monocyte Adhesion Is Modulated By Kininogen, Kallikrein, Factor Xii, And Plasminogen

[Expression of Urokinase-Type Plasminogen Activator and Its Receptor in Plasma of Patients with Cerebral Infarction].

The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide

Urokinase-Type Plasminogen Activator Up-Regulates Its Own Expression by Endothelial Cells and Monocytes Via the U-Par Pathway

The changes of plasminogen activator and other molecules in regeneration and recovery after optic nerve injury

Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator

Effects of Rt-Pa Intravenous Thrombolysis on Blood-Brain Barrier Permeability, the Expressions and the Activities of MMP-2 and MMP-9 after Cerebral Ischemia in Rats

C16 Peptide and Angiopoietin-1 Protect Against LPS-induced BV-2 Microglial Cell Inflammation.